Cyklokapron Articles
Bayer temporarily stops Trasylol marketing
21 November 2007
New Trasylol warnings after BART study deaths
5 November 2007
Bayer's Trasylol linked to CABG mortality risk
12 February 2007
Icatibant yields fast symptom improvement
23 October 2006
FDA public advisory on Bayer
9 October 2006
Positive results for icatibant in HAE trials
2 October 2006
Jerini sees progress in Icatibant HAE study
7 August 2006
Israel's Omrixplanning IPO in USA
15 September 2000
Dutch Government Reimbursement Blacklist Rises To 35
9 December 1996
Showing 1-10 of 10 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
